As versatile drug delivery systems, polymeric micelles have demonstrated particular strength in solubilizing hydrophobic anticancer drugs while eliminating the use of toxic organic solvents and surfactants. However, the true promise of polymeric micelles as drug carriers for cancer therapy resides in their potential ability to preferentially elevate drug exposure in the tumor and achieve enhanced anticancer efficacy, which still remains to be fully exploited. Here, we review various micellar constructs that exhibit the enhanced permeation and retention effect in the tumor, the targeting ligands that potentiate the anticancer efficacy of micellar drugs, and the polyplex micelle systems suitable for the delivery of plasmid DNA and small interference RNA. Together, these preclinical studies in animal models help us further explore polymeric micelles as emerging drug carriers for targeted cancer therapy.
References
[1]
Gong, J.; Chen, M.; Zheng, Y.; Wang, S.; Wang, Y. Polymeric micelles drug delivery system in oncology. J. Control. Release 2012, 159, 312–323, doi:10.1016/j.jconrel.2011.12.012.
[2]
Maeda, H.; Nakamura, H.; Fang, J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 2013, 65, 71–79, doi:10.1016/j.addr.2012.10.002.
[3]
Xu, S.; Olenyuk, B.Z.; Okamoto, C.T.; Hamm-Alvarez, S.F. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Deliv. Rev. 2013, 65, 121–138, doi:10.1016/j.addr.2012.09.041.
[4]
Blanco, E.; Kessinger, C.W.; Sumer, B.D.; Gao, J. Multifunctional micellar nanomedicine for cancer therapy. Exp. Biol. Med. 2009, 234, 123–131.
[5]
Kwon, G.S.; Kataoka, K. Block copolymer micelles as long-circulating drug vehicles. Adv. Drug Deliv. Rev. 2012, 64, 237–245, doi:10.1016/j.addr.2012.09.016.
Blanco, E.; Bey, E.A.; Khemtong, C.; Yang, S.G.; Setti-Guthi, J.; Chen, H.; Kessinger, C.W.; Carnevale, K.A.; Bornmann, W.G.; Boothman, D.A.; et al. β-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Res. 2010, 70, 3896–3904, doi:10.1158/0008-5472.CAN-09-3995.
[8]
Mu, C.F.; Balakrishnan, P.; Cui, F.D.; Yin, Y.M.; Lee, Y.B.; Choi, H.G.; Yong, C.S.; Chung, S.J.; Shim, C.K.; Kim, D.D. The effects of mixed MPEG–PLA/Pluronic？ copolymer micelles on the bioavailability and multidrug resistance of docetaxeltaxel. Biomaterials 2010, 31, 2371–2379, doi:10.1016/j.biomaterials.2009.11.102.
[9]
Tang, N.; Du, G.; Wang, N.; Liu, C.; Hang, H.; Liang, W. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J. Natl. Cancer Inst. 2007, 99, 1004–1015, doi:10.1093/jnci/djm027.
[10]
Tong, S.W.; Xiang, B.; Dong, D.W.; Qi, X.R. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int. J. Pharm. 2012, 434, 413–419, doi:10.1016/j.ijpharm.2012.06.014.
[11]
Katragadda, U.; Fan, W.; Wang, Y.; Teng, Q.; Tan, C. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis. PLoS One 2013, 8, e58619, doi:10.1371/journal.pone.0058619.
[12]
Kawano, K.; Watanabe, M.; Yamamoto, T.; Yokoyama, M.; Opanasopit, P.; Okano, T.; Maitani, Y. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J. Control. Release 2006, 112, 329–332, doi:10.1016/j.jconrel.2006.03.012.
[13]
Okuda, T.; Kawakami, S.; Higuchi, Y.; Satoh, T.; Oka, Y.; Yokoyama, M.; Yamashita, F.; Hashida, M. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles. Int. J. Pharm. 2009, 373, 100–106, doi:10.1016/j.ijpharm.2009.01.019.
[14]
Zhang, L.; He, Y.; Ma, G.; Song, C.; Sun, H. Paclitaxel-loaded polymeric micelles based on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) triblock copolymers: In vitro and in vivo evaluation. Nanomedicine 2012, 8, 925–934, doi:10.1016/j.nano.2011.11.005.
[15]
Peng, C.L.; Lai, P.S.; Lin, F.H.; Wu, S.Y.-H.; Shieh, M.J. Dual chemotherapy and photodynamic therapy in an HT-29 human colon cancer xenograft model using SN-38-loaded chlorin-core star block copolymer micelles. Biomaterials 2009, 30, 3614–3625.
[16]
Zhang, W.; Shi, Y.; Chen, Y.; Hao, J.; Sha, X.; Fang, X. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 2011, 32, 5934–5944, doi:10.1016/j.biomaterials.2011.04.075.
[17]
Wang, Y.; Hao, J.; Li, Y.; Zhang, Z.; Sha, X.; Han, L.; Fang, X. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors. Biomaterials 2012, 33, 4741–4751, doi:10.1016/j.biomaterials.2012.03.013.
[18]
Jadhav, V.B.; Jun, Y.J.; Song, J.H.; Park, M.K.; Oh, J.H.; Chae, S.W.; Kim, I.S.; Choi, S.J.; Lee, H.J.; Sohn, Y.S. A novel micelle-encapsulated platinum (II) anticancer agent. J. Control. Release 2010, 147, 144–150, doi:10.1016/j.jconrel.2010.07.101.
[19]
Jun, Y.J.; Jadhav, V.B.; Min, J.H.; Cui, J.X.; Chae, S.W.; Choi, J.M.; Kim, I.S.; Choi, S.J.; Lee, H.J.; Sohn, Y.S. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile. Int. J. Pharm. 2012, 31, 374–380.
[20]
Ko, J.; Park, K.; Kim, Y.-S.; Kim, M.S.; Han, J.K.; Kim, K.; Park, R.-W.; Kim, I.-S.; Song, H.Y.; Lee, D.S.; et al. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(β-amino ester) block copolymer micelles for cancer therapy. J. Control. Release 2007, 123, 109–115.
[21]
Min, K.H.; Kim, J.-H.; Bae, S.M.; Shin, H.; Kim, M.S.; Park, S.; Lee, H.; Park, R.-W.; Kim, I.-S.; Kim, K.; et al. Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy. J. Control. Release 2010, 144, 259–266, doi:10.1016/j.jconrel.2010.02.024.
Xiao, K.; Li, Y.; Luo, J.; Lee, J.S.; Xiao, W.; Gonik, A.M.; Agarwal, R.G.; Lam, K.S. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. J. Control. Release 2011, 155, 272–281, doi:10.1016/j.jconrel.2011.07.018.
[24]
Gao, Z.G.; Tian, L.; Hu, J.; Park, I.S.; Bae, Y.H. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. J. Control. Release 2011, 1521, 84–89.
[25]
Kim, D.; Gao, Z.G.; Lee, E.S.; Bae, Y.H. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol. Pharm. 2009, 6, 1353–1362, doi:10.1021/mp900021q.
[26]
Tsai, H.C.; Chang, W.H.; Lo, C.L.; Tsai, C.H.; Chang, C.H.; Ou, T.W.; Yen, T.C.; Hsiue, G.H. Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials 2010, 31, 2293–2301.
[27]
Zhang, W.; Shi, Y.; Chen, Y.; Ye, J.; Sha, X.; Fang, X. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 2011, 32, 2894–2906, doi:10.1016/j.biomaterials.2010.12.039.
[28]
Syu, W.J.; Yu, H.P.; Hsu, C.Y.; Rajan, Y.C.; Hsu, Y.H.; Chang, Y.C.; Hsieh, W.Y.; Wang, C.H.; Lai, P.S. Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model. Small 2012, 8, 2060–2069, doi:10.1002/smll.201102695.
[29]
Zhang, P.; Hu, L.; Yin, Q.; Zhang, Z.; Feng, L.; Li, Y. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J. Control. Release 2012, 159, 429–434, doi:10.1016/j.jconrel.2012.01.031.
Zhao, B.J.; Ke, X.Y.; Huang, Y.; Chen, X.M.; Zhao, X.; Zhao, B.X.; Lu, W.L.; Lou, J.N.; Zhang, X.; Zhang, Q. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. J. Drug Target. 2011, 19, 382–390, doi:10.3109/1061186X.2010.504267.
[32]
Ying, L.; Lei, Y.; Wagner, E.; Xie, C.; Lu, W.; Zhu, J.; Shen, J.; Wang, J.; Liu, M. Potent retro-inverso d-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells. Bioconjug. Chem. 2013, 24, 133–143, doi:10.1021/bc300537z.
[33]
Xiao, K.; Li, Y.; Lee, J.S.; Gonik, A.M.; Dong, T.; Fung, G.; Sanchez, E.; Xing, L.; Cheng, H.R.; Luo, J.; et al. “OA02” peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Cancer Res. 2012, 72, 2100–2110, doi:10.1158/0008-5472.CAN-11-3883.
[34]
Sawant, R.R.; Torchilin, V.P. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int. J. Pharm. 2009, 31, 114–118, doi:10.1016/j.ijpharm.2009.02.022.
[35]
Zheng, N.; Dai, W.; Du, W.; Zhang, H.; Lei, L.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Gao, J.; et al. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors. Mol. Pharm. 2012, 9, 1175–1188.
[36]
Wang, Z.; Yu, Y.; Ma, J.; Zhang, H.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics. Mol. Pharm. 2012, 9, 2646–2657, doi:10.1021/mp3002107.
[37]
Wu, X.L.; Kim, J.H.; Koo, H.; Bae, S.M.; Shin, H.; Kim, M.S.; Lee, B.H.; Park, R.W.; Kim, I.S.; Choi, K.; et al. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug. Chem. 2010, 21, 208–213, doi:10.1021/bc9005283.
[38]
Lu, Y.; Low, P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 2012, 64, 342–352, doi:10.1016/j.addr.2012.09.020.
[39]
Daniels, T.R.; Bernabeu, E.; Rodríguez, J.A.; Patel, S.; Kozman, M.; Chiappetta, D.A.; Holler, E.; Ljubimova, J.Y.; Helguera, G.; Penichet, M.L. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim. Biophys. Acta 2012, 1820, 291–317, doi:10.1016/j.bbagen.2011.07.016.
[40]
Desgrosellier, J.S.; Cheresh, D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10, 9–22, doi:10.1038/nrc2748.
[41]
Curnis, F.; Arrigoni, G.; Sacchi, A.; Fischetti, L.; Arap, W.; Pasqualini, R.; Corti, A. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res. 2002, 62, 867–874.
[42]
Lee, T.Y.; Lin, C.T.; Kuo, S.Y.; Chang, D.K.; Wu, H.C. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery. Cancer Res. 2007, 67, 10958–10965, doi:10.1158/0008-5472.CAN-07-2233.
[43]
Bolhassani, A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim. Biophys. Acta 2011, 1816, 232–246.
Laakkonen, P.; Porkka, K.; Hoffman, J.A.; Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 2002, 8, 751–755.
[46]
Leland, P.; Taguchi, J.; Husain, S.R.; Kreitman, R.J.; Pastan, I.; Puri, R.K. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. Mol. Med. 2000, 6, 165–178.
Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Control. Release 2011, 152, 2–12, doi:10.1016/j.jconrel.2011.01.030.
[49]
Lee, S.Y.; Kim, S.; Tyler, J.Y.; Park, K.; Cheng, J.X. Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy. Biomaterials 2013, 34, 552–561, doi:10.1016/j.biomaterials.2012.09.065.
Osada, K.; Christie, R.J.; Kataoka, K. Polymeric micelles from poly (ethylene glycol)–poly (amino acid) block copolymer for drug and gene delivery. J. R. Soc. Interface 2009, 6, S325–S339, doi:10.1098/rsif.2008.0547.focus.
[55]
Lee, S.H.; Chung, B.H.; Park, T.G.; Nam, Y.S.; Mok, H. Small-interfering RNA (siRNA)-based functional micro-and nanostructures for efficient and selective gene silencing. Acc. Chem. Res. 2012, 45, 1014–1025, doi:10.1021/ar2002254.
[56]
Davidson, B.L.; McCray, P.B., Jr. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 2011, 329–340, doi:10.1038/nrg2968.
[57]
Oba, M.; Vachutinsky, Y.; Miyata, K.; Kano, M.R.; Ikeda, S.; Nishiyama, N.; Itaka, K.; Miyazono, K.; Koyama, H.; Kataoka, K. Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble Flt-1. Mol. Pharm. 2010, 7, 501–509.
[58]
Vachutinsky, Y.; Oba, M.; Miyata, K.; Hiki, S.; Kano, M.R.; Nishiyama, N.; Koyama, H.; Miyazono, K.; Kataoka, K. Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles. J. Control. Release 2011, 149, 51–57, doi:10.1016/j.jconrel.2010.02.002.
[59]
Kumagai, M.; Shimoda, S.; Wakabayashi, R.; Kunisawa, Y.; Ishii, T.; Osada, K.; Itaka, K.; Nishiyama, N.; Kataoka, K.; Nakano, K. Effective transgene expression without toxicity by intraperitoneal administration of PEG-detachable polyplex micelles in mice with peritoneal dissemination. J. Control. Release 2012, 2012, 542–551.
[60]
Christie, R.J.; Matsumoto, Y.; Miyata, K.; Nomoto, T.; Fukushima, S.; Osada, K.; Halnaut, J.; Pittella, F.; Kim, H.J.; Nishiyama, N.; et al. Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection. ACS Nano 2012, 6, 5174–5189, doi:10.1021/nn300942b.
[61]
Kim, S.H.; Jeong, J.H.; Lee, S.H.; Kim, S.W.; Park, T.G. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control. Release 2008, 129, 107–116, doi:10.1016/j.jconrel.2008.03.008.
[62]
Mao, C.Q.; Du, J.Z.; Sun, T.M.; Yao, Y.D.; Zhang, P.Z.; Song, E.W.; Wang, J. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials 2011, 32, 3124–3133, doi:10.1016/j.biomaterials.2011.01.006.
[63]
Sun, T.M.; Du, J.Z.; Yao, Y.D.; Mao, C.Q.; Dou, S.; Huang, S.Y.; Zhang, P.Z.; Leong, K.W.; Song, E.W.; Wang, J. Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano 2011, 5, 1483–1494, doi:10.1021/nn103349h.
